MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00125-026-06895-z

Медицинская библиотека · Diabetologia · 2026

CGM-derived disposition index estimates beta cell function in individuals with islet autoimmunity who do not require insulin treatment; changes in the disposition index precede changes identified by CGM metrics 1 year later.

Marchiori Hadija, Schiavon Michele, Tichy Eileen, Alguard Michele, DeSousa Marcia, Del Favero Simone, Gaglia Jason L, Sherr Jennifer L, Dalla Man Chiara, Galderisi Alfonso

СтатьяПеревод пока не подготовлен

Аннотация

AIMS/HYPOTHESIS: Monitoring of beta cell function in individuals with islet autoimmunity who do not require insulin treatment (preclinical type 1 diabetes) is normally done via OGTTs, posing major challenges given the invasiveness of the test. Here, we validated a disposition index (DI) derived from continuous glucose monitoring (CGM) metrics (DICGM), which is a proxy of beta cell function, against the gold-standard OGTT DI (DIMM), in a cohort of individuals with one or more islet autoantibodies who do not require insulin treatment.

METHODS

Participants underwent a 3 h 10-point OGTT with measurement of glucose, insulin and C-peptide while wearing a blinded CGM. The sensor was started 24 h prior to the OGTT. DICGM was computed using CGM data during the 3 h OGTT and two blood glucose calibrations, and compared with the DI from the oral minimal model (DIMM), which uses plasma glucose, insulin and C-peptide. The association between the baseline DICGM and duration of glucose levels above 7.8 mmol/l (140 mg/dl) (TA140) at 1 year was explored.

RESULTS

Twenty-four participants (median age 16.8 years [IQR 13.5-27.7] ) were enrolled, of whom 18 completed both the OGTT (ten with pre-stage 1, seven with stage 1 and one with stage 3a type 1 diabetes) and CGM at baseline, and had repeat CGM 1 year later. The baseline DICGM was highly correlated with the DIMM (r=0.90, p<0.001). Lower baseline DICGM was associated with higher 1 year TA140 (r=-0.61, p=0.014) and higher 1 year mean sensor glucose (r=-0.62, p=0.020).

CONCLUSIONS/INTERPRETATION: Beta cell function can be estimated using CGM during a glucose load. DICGM correlates with a 1 year clinically relevant outcome (TA140) in individuals with islet autoimmunity who do not require insulin therapy.

Для цитирования: Marchiori Hadija, Schiavon Michele, Tichy Eileen, Alguard Michele, DeSousa Marcia, Del Favero Simone, Gaglia Jason L, Sherr Jennifer L, Dalla Man Chiara, Galderisi Alfonso. CGM-derived disposition index estimates beta cell function in individuals with islet autoimmunity who do not require insulin treatment; changes in the disposition index precede changes identified by CGM metrics 1 year later.. Diabetologia. 2026. DOI: 10.1007/s00125-026-06895-z.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.